Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators

Details for Australian Patent Application No. 2008286976 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Wachter, Michael P.; Pan, Meng; Xia, Mingde

Agent Shelston IP

Pub. Number AU-A-2008286976

PCT Pub. Number WO2009/023653

Priority 60/955,411 13.08.07 US

Filing date 12 August 2008

Wipo publication date 19 February 2009

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/5377 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07D 231/14 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 413/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

4 March 2010 PCT application entered the National Phase

  PCT publication WO2009/023653 Priority application(s): WO2009/023653

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008286979-Quaternary opioid carboxamides

2008286962-Modified peptides having toxinenhancing effects